Related references
Note: Only part of the references are listed.Considerations for the Design of Antibody-Based Therapeutics
Dennis R. Goulet et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
An IgG1 Version of the Anti-transferrin Receptor 1 Antibody ch128.1 Shows Significant Antitumor Activity Against Different Xenograft Models of Multiple Myeloma: A Brief Communication
Tracy R. Daniels-Wells et al.
JOURNAL OF IMMUNOTHERAPY (2020)
Discovering Therapeutic Protein Targets for Bladder Cancer Using Proteomic Data Analysis
Samira Bahrami et al.
CURRENT MOLECULAR PHARMACOLOGY (2020)
TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
Xiaojing Cheng et al.
CELL DEATH & DISEASE (2020)
Gene Silencing of Transferrin-1 Receptor as a Potential Therapeutic Target for Human Follicular and Anaplastic Thyroid Cancer
Agata Campisi et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
CX-2029, a PROBODY drug conjugate targeting CD71 (transferrin receptor): Results from a first-in-human study (PROCLAIM-CX-2029) in patients (Pts) with advanced cancer.
Melissa Lynne Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Transferrin receptor 1 targeted optical imaging for identifying glioma margin in mouse models
Xiang-Rong Ni et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Iron: The cancer connection
Suzy V. Torti et al.
MOLECULAR ASPECTS OF MEDICINE (2020)
Transferrin Receptors in Erythropoiesis
Cyrielle Richard et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation
Chong Xiao et al.
PLOS ONE (2020)
Targeting transferrin receptor 1 (TfR1) with the ch128.1/IgG1 antibody inhibits Epstein-Barr virus (EBV) driven lymphoproliferative growth and lymphomagenesis in immunosuppressed mice bearing human B cells
Laura E. Martinez et al.
CANCER RESEARCH (2020)
Combination therapy with an antibody specific for transferrin receptor 1 (ch128.1/IgG1) and bortezomib or lenalidomide results in increased survival in an in vivo model of human multiple myeloma
Pierre Candelaria et al.
CANCER RESEARCH (2020)
Efficacy of antibodies targeting TfR1 in xenograft mouse models of AIDS-related non-Hodgkin lymphoma
Tracy R. Daniels-Wells et al.
CANCER RESEARCH (2020)
Protein Expression of Cyclin B1, Transferrin Receptor, and Fibronectin Is Correlated with the Prognosis of Adrenal Cortical Carcinoma
Sun Joon Moon et al.
ENDOCRINOLOGY AND METABOLISM (2020)
Transferrin and transferrin receptors update
Hiroshi Kawabata
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Glucocorticoids in multiple myeloma: past, present, and future
Nicholas Burwick et al.
ANNALS OF HEMATOLOGY (2019)
Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma
Makiko Adachi et al.
HISTOPATHOLOGY (2019)
Cryo-EM structure of the human ferritin-transferrin receptor 1 complex
Linda Celeste Montemiglio et al.
NATURE COMMUNICATIONS (2019)
miR-148a regulates expression of the transferrin receptor 1 in hepatocellular carcinoma
Kamesh R. Babu et al.
SCIENTIFIC REPORTS (2019)
MiR-107 function as a tumor suppressor gene in colorectal cancer by targeting transferrin receptor 1
Yuxiang Fu et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2019)
A novel iron(II) phenanthroline complex exhibits anticancer activity against TFR1-overexpressing esophageal squamous cell carcinoma cells through ROS accumulation and DNA damage
Jiecheng Ye et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Transferrin receptor-1 and VEGF are prognostic factors for osteosarcoma
Hongzeng Wu et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2019)
Over-Expression of Transferrin Receptor (TFRC/CD71) and Low Expression of Innate and Adaptive Immune Cell Subsets in HIV-Associated, GCB-DLBCL By Digital Gene Expression Profiling
Alanna Maguire et al.
BLOOD (2019)
Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer
Xiaofeng Xu et al.
CANCER GENE THERAPY (2019)
Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk
Tao Sun et al.
CANCER RESEARCH (2019)
A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions
Madeline Neiveyans et al.
MABS (2019)
Transferrin Receptors TfR1 and TfR2 Bind Transferrin through Differing Mechanisms
Mark D. Kleven et al.
BIOCHEMISTRY (2018)
Efficacy and Mechanism of Antitumor Activity of an Antibody Targeting Transferrin Receptor 1 in Mouse Models of Human Multiple Myeloma
Lai Sum Leoh et al.
JOURNAL OF IMMUNOLOGY (2018)
Prognostic Value of Transferrin Receptor-1 (CD71) Expression in Acute Lymphoblastic Leukemia
Adel A. Hagag et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2018)
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy
Juan C. Almagro et al.
FRONTIERS IN IMMUNOLOGY (2018)
Iron metabolism gene expression and prognostic features of hepatocellular carcinoma
Ying Shen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Biological determinants of health disparities in multiple myeloma
Cheryl Jacobs Smith et al.
BLOOD CANCER JOURNAL (2018)
Emerging and Dynamic Biomedical Uses of Ferritin
Brian Chiou et al.
PHARMACEUTICALS (2018)
Expression of Iron-Related Proteins Differentiate Non-Cancerous and Cancerous Breast Tumors
Sara Pizzamiglio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The transferrin receptor: the cellular iron gate
Elena Gammella et al.
METALLOMICS (2017)
Iron addiction: a novel therapeutic target in ovarian cancer
D. Basuli et al.
ONCOGENE (2017)
Antibody Isotypes for Tumor Immunotherapy
Anna Kretschmer et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2017)
Upregulation of transferrin receptor-I induces cholangiocarcinoma progression via induction of labile iron pool
Wassana Jamnongkan et al.
TUMOR BIOLOGY (2017)
Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients
Christopher J. Greene et al.
ONCOTARGET (2017)
Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value
Ann Mari Rosager et al.
PLOS ONE (2017)
PPMX-T003, a fully human anti-TfR1 antibody with potent efficacy against hematologic malignancies
Lilin Zhang et al.
CANCER RESEARCH (2017)
Decreased Iron in Cancer Cells and Their Microenvironment Improves Cytolysis of Breast Cancer Cells by Natural Killer Cells
Xian-Peng Jiang et al.
ANTICANCER RESEARCH (2017)
Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphoma
Shunsuke Shimosaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Transferrin receptor regulates pancreatic cancer growth by modulating mitochondrial respiration and ROS generation
Seung Min Jeong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal Tumorigenesis
Xiang Xue et al.
CELL METABOLISM (2016)
Oncogenic regulation of tumor metabolic reprogramming
Miriam Tarrado-Castellarnau et al.
ONCOTARGET (2016)
Decreased Ferroportin Promotes Myeloma Cell Growth and Osteoclast Differentiation
Zhimin Gu et al.
CANCER RESEARCH (2015)
Antibody-Dependent Phagocytosis of Tumor Cells by Macrophages: A Potent Effector Mechanism of Monoclonal Antibody Therapy of Cancer
Nuray Guel et al.
CANCER RESEARCH (2015)
Cellular and Molecular Mechanisms of Inflammation-induced Angiogenesis
Agata Szade et al.
IUBMB LIFE (2015)
Efficacy of an Anti-transferrin Receptor 1 Antibody Against AIDS-related Non-Hodgkin Lymphoma: A Brief Communication
Tracy R. Daniels-Wells et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1
Lai Sum Leoh et al.
MOLECULAR IMMUNOLOGY (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
Wei Wang et al.
FRONTIERS IN IMMUNOLOGY (2015)
HIF-1α pathway: role, regulation and intervention for cancer therapy
Georgina N. Masoud et al.
ACTA PHARMACEUTICA SINICA B (2015)
SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1
S. M. Jeong et al.
ONCOGENE (2015)
H-Ferritin Is Preferentially Incorporated by Human Erythroid Cells through Transferrin Receptor 1 in a Threshold-Dependent Manner
Soichiro Sakamoto et al.
PLOS ONE (2015)
The ins and outs of MHC class II-mediated antigen processing and presentation
Paul A. Roche et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Interplay between sirtuins, MYC and hypoxia-inducible factor in cancer-associated metabolic reprogramming
Bernadette M. M. Zwaans et al.
DISEASE MODELS & MECHANISMS (2014)
Complement in monoclonal antibody therapy of cancer
Laura M. Rogers et al.
IMMUNOLOGIC RESEARCH (2014)
Gene delivery in malignant B cells using the combination of lentiviruses conjugated to anti- transferrin receptor antibodies and an immunoglobulin promoter
Lai Sum Leoh et al.
JOURNAL OF GENE MEDICINE (2014)
Overexpression of transferrin receptor CD71 and its tumorigenic properties in esophageal squamous cell carcinoma
Kin Tak Chan et al.
ONCOLOGY REPORTS (2014)
Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71
Rosalba Parenti et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Essential functions of iron-requiring proteins in DNA replication, repair and cell cycle control
Caiguo Zhang
PROTEIN & CELL (2014)
Development of a complete human anti-human transferrin receptor C antibody as a novel marker of oral dysplasia and oral cancer
Kentaro Nagai et al.
CANCER MEDICINE (2014)
The role of Fc gamma receptors in the activity of immunomodulatory antibodies for cancer
Ross Stewart et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
TfR1 interacts with the IKK complex and is involved in IKK-NF-kappa B signalling
Niall S. Kenneth et al.
BIOCHEMICAL JOURNAL (2013)
Sinomenine hydrochloride enhancement of the inhibitory effects of anti-transferrin receptor antibody-dependent on the COX-2 pathway in human hepatoma cells
Yi Hong et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain Barrier
Jessica A. Couch et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Insights into the mechanism of cell death induced by saporin delivered into cancer cells by an antibody fusion protein targeting the transferrin receptor 1
Tracy R. Daniels-Wells et al.
TOXICOLOGY IN VITRO (2013)
Mechanism of action of therapeutic monoclonal antibodies: Promises and pitfalls of in vitro and in vivo assays
Josee Golay et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
The transferrin receptor and the targeted delivery of therapeutic agents against cancer
Tracy R. Daniels et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Crosstalk between Human IgG Isotypes and Murine Effector Cells
Marije B. Overdijk et al.
JOURNAL OF IMMUNOLOGY (2012)
An Antibody Recognizing the Apical Domain of Human Transferrin Receptor 1 Efficiently Inhibits the Entry of All New World Hemorrhagic Fever Arenaviruses
Gustavo Helguera et al.
JOURNAL OF VIROLOGY (2012)
A Minimal Connected Network of Transcription Factors Regulated in Human Tumors and Its Application to the Quest for Universal Cancer Biomarkers
Ahmed Essaghir et al.
PLOS ONE (2012)
2011: the immune hallmarks of cancer
Federica Cavallo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
An anti-transferrin receptor antibody enhanced the growth inhibitory effects of chemotherapeutic drugs on human glioma cells
Guozheng Xu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Antigen-Presenting Cell (APC) Subsets in Ovarian Cancer
Cailin Moira Wilke et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2011)
Src Regulates Tyr20 Phosphorylation of Transferrin Receptor-1 and Potentiates Breast Cancer Cell Survival
Jinlong Jian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
An Antibody-based Multifaceted Approach Targeting the Human Transferrin Receptor for the Treatment of B-cell Malignancies
Tracy R. Daniels et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells
Jose A. geead Rodriguez et al.
LEUKEMIA & LYMPHOMA (2011)
How the binding of human transferrin primes the transferrin receptor potentiating iron release at endosomal pH
Brian E. Eckenroth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients
Ivan C Moura et al.
Retrovirology (2011)
Evolutionary Conserved Regulation of HIF-1 beta by NF-kappa B
Patrick van Uden et al.
PLOS GENETICS (2011)
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen
Hany Onsy Habashy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Development of Human Single-Chain Antibodies to the Transferrin Receptor that Effectively Antagonize the Growth of Leukemias and Lymphomas
Ronan Crepin et al.
CANCER RESEARCH (2010)
Characterization and phenotypic analysis of differentiating CD34+human bone marrow cells in liquid culture
Sherilyn Gross et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Inhibition of NF-κB and Akt pathways by an antibody-avidin fusion protein sensitizes malignant B-cells to cisplatin-induced apoptosis
Eriko Suzuki et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia
Celine Callens et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells
T. R. Daniels et al.
LEUKEMIA (2010)
Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol
Des R. Richardson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Binding and uptake of H-ferritin are mediated by human transferrin receptor-1
Li Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide
Kouki Morizono et al.
JOURNAL OF GENE MEDICINE (2009)
A loop in the N-lobe of human serum transferrin is critical for binding to the transferrin receptor as revealed by mutagenesis, isothermal titration calorimetry, and epitope mapping
Anne B. Mason et al.
JOURNAL OF MOLECULAR RECOGNITION (2009)
Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species
E. Ortiz-Sanchez et al.
LEUKEMIA (2009)
Human immunoglobulin allotypes Possible implications for immunogenicity
Roy Jefferis et al.
MABS (2009)
Simultaneous induction of apoptotic, autophagic, and necrosis-like cell death by monoclonal antibodies recognizing chicken transferrin receptor
Yoshiya Ohno et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Regulation of hypoxia-inducible factor-1α by NF-κB
Patrick van Uden et al.
BIOCHEMICAL JOURNAL (2008)
Roles of hormone replacement therapy, and iron in proliferation of breast epithelial cells with different estrogen and progesterone receptor status
Jisen Dai et al.
BREAST (2008)
Cell-death-inducing monoclonal antibodies raised against DT40 tumor cells: Identification of chicken transferrin receptor as a novel cell-death receptor
Yoshiya Ohno et al.
CANCER SCIENCE (2008)
Overexpression of cellular iron import proteins is associated with malignant progression of Esophageal adenocarcinoma
Jessica Boult et al.
CLINICAL CANCER RESEARCH (2008)
An anti-transferrin receptor antibody enhanced the growth inhibitory effects of chemotherapeutic drugs on human non-hematopoietic tumor cells
Xin Shen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Role of HIF-1 and NF-κB transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals
Lorenza Tacchini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Phenotypic and Functional Reversal Within the Early Human Hematopoietic Compartment
Shoshan Knaan-Shanzer et al.
STEM CELLS (2008)
Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo
M. Wang et al.
LEUKEMIA (2008)
Recent advances in adult T-cell leukemia therapy: focus on a new anti-transferrin receptor monoclonal antibody
C. Callens et al.
LEUKEMIA (2008)
Binding specificity and internalization properties of an antibody -: avidin fusion protein targeting the human transferrin receptor
Jose A. Rodriguez et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Conjugation of an anti-transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells
Tracy R. Daniels et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Antigen-binding characteristics of AbCD71 and its inhibitory effect on PHA-induced lymphoproliferation
Ping Lei et al.
ACTA PHARMACOLOGICA SINICA (2007)
Downregulation of transferrin receptor surface expression by intracellular antibody
Ji-Lin Peng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles
Daniel R. Rhodes et al.
NEOPLASIA (2007)
Prevention of mantle lymphoma tumor establishment by routing transferrin receptor toward lysosomal compartments
Yves Lepelletier et al.
CANCER RESEARCH (2007)
The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer
Tracy R. Daniels et al.
CLINICAL IMMUNOLOGY (2006)
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
Tracy R. Daniels et al.
CLINICAL IMMUNOLOGY (2006)
Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor
Patrick P. Ng et al.
BLOOD (2006)
Application and potential limitations of animal models utilized in the development of trastuzumab (Herceptin®):: A case study
Mark Pegram et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis
KA O'Donnell et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate
DT Jones et al.
CANCER RESEARCH (2006)
The in vitro antitumor effect and in vivo tumor-specificity distribution of human-mouse chimeric antibody against transferrin receptor
Ye Qing et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Divergent immunoglobulin G subclass activity through selective Fc receptor binding
F Nimmerjahn et al.
SCIENCE (2005)
Balancing acts: Molecular control of mammalian iron metabolism
MW Hentze et al.
CELL (2004)
A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients
IC Moura et al.
BLOOD (2004)
Ferritin heavy chain upregulation by NF-κB inhibits TNFα-induced apoptosis by suppressing reactive oxygen species
CG Pham et al.
CELL (2004)
Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas
E Ryschich et al.
EUROPEAN JOURNAL OF CANCER (2004)
An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells
PP Ng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
H Tanaka et al.
NATURE (2000)
Share Paper
